BeyondKrill™X2 is a next-generation bonded phospholipid omega-3 formulation designed to take phospholipid nutrition beyond the limitations of conventional krill oil. Delivering 2X the EPA + DHA concentration of conventional krill oil, it gives brands a ready-to-commercialize solution for more advanced omega-3 formulations.
What sets BeyondKrill™X2 apart is not simply how many phospholipids it contains, but how much omega-3 is actually bonded to them. Its advanced lipid architecture features EPA + DHA bonded to phospholipids rather than simply blending the two as separate components.
Why does bonding matter? Phospholipids are natural components of cell membranes and important lipid carriers in the body. Bonding EPA + DHA to phospholipids is designed to support the journey of omega-3 beyond absorption toward cellular incorporation.
With 2X the EPA + DHA concentration of conventional krill oil, BeyondKrill™X2 enables more omega-3 in smaller, more efficient serving formats. Delivering 450 mg of EPA + DHA per serving, it is also 100% shellfish-free and designed for a neutral taste, helping brands move beyond key source and formulation limitations traditionally associated with krill.
The result is a differentiated, market-ready formulation for premium products targeting heart health, healthy aging, and overall wellness.
BeyondKrill™X2 is powered by Ruby-O®, Naturmega's BPL-O3™ technology platform for bonded phospholipid omega-3. Ruby-O® enables the design of advanced lipid architectures across different omega-3 sources, phospholipid profiles, nutritional targets, and applications.
BeyondKrill™ represents the broader innovation territory, bringing this technology into a new generation of alternatives to conventional krill oil. BeyondKrill X2™ is one expression of that territory, translating advanced lipid design into a ready-to-commercialize, high-strength EPA + DHA formulation.
Its scientific foundation combines NMR structural characterization and proprietary a
